Caxton Associates LP Has $684,000 Holdings in Premier, Inc. (NASDAQ:PINC)

Caxton Associates LP trimmed its stake in shares of Premier, Inc. (NASDAQ:PINC) by 53.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 32,268 shares of the company’s stock after selling 36,905 shares during the period. Caxton Associates LP’s holdings in Premier were worth $684,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of PINC. Brooklyn Investment Group lifted its stake in shares of Premier by 61,750.0% during the fourth quarter. Brooklyn Investment Group now owns 1,237 shares of the company’s stock valued at $26,000 after acquiring an additional 1,235 shares during the period. SRS Capital Advisors Inc. boosted its stake in shares of Premier by 157.8% in the 4th quarter. SRS Capital Advisors Inc. now owns 1,284 shares of the company’s stock valued at $27,000 after purchasing an additional 786 shares during the last quarter. Keystone Financial Group Inc. acquired a new stake in shares of Premier during the 4th quarter worth approximately $37,000. Wilmington Savings Fund Society FSB bought a new stake in shares of Premier during the third quarter worth approximately $39,000. Finally, Smartleaf Asset Management LLC lifted its holdings in Premier by 297.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,906 shares of the company’s stock valued at $40,000 after buying an additional 1,427 shares during the period. Institutional investors and hedge funds own 74.41% of the company’s stock.

Insider Buying and Selling

In related news, General Counsel David L. Klatsky sold 10,000 shares of the stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $19.53, for a total transaction of $195,300.00. Following the completion of the transaction, the general counsel now owns 90,597 shares in the company, valued at approximately $1,769,359.41. This represents a 9.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.96% of the company’s stock.

Analyst Upgrades and Downgrades

PINC has been the subject of several recent research reports. Piper Sandler dropped their target price on shares of Premier from $21.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Robert W. Baird reduced their target price on Premier from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Finally, Canaccord Genuity Group decreased their target price on Premier from $21.00 to $19.00 and set a “hold” rating for the company in a research report on Wednesday, February 5th. Eight equities research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $20.17.

Premier Stock Performance

Shares of PINC opened at $22.94 on Wednesday. The firm has a market cap of $2.09 billion, a P/E ratio of -229.38 and a beta of 0.54. Premier, Inc. has a twelve month low of $17.23 and a twelve month high of $23.56. The firm’s 50 day moving average price is $19.19 and its two-hundred day moving average price is $20.48.

Premier Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Sunday, June 15th. Investors of record on Sunday, June 1st will be given a $0.21 dividend. The ex-dividend date is Friday, May 30th. This represents a $0.84 annualized dividend and a yield of 3.66%. Premier’s dividend payout ratio is currently -840.00%.

Premier Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.